secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001493152-24-002010
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics appoints Robert Gagnon to board of directors, replacing Erick Lucera
--------------------------------------------------------------------------------

- Robert Gagnon appointed to board effective Jan 8, 2024; Erick Lucera resigned same date.
- Gagnon will chair audit committee and serve on compensation and nominating committees.
- He brings 20+ years finance experience; currently CFO of Remix Therapeutics.
- Board size remains at four members after appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer